Kenneth W. Sommerville

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 887 citations

Medicine, Neurology, Pharmacology +9

Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome

Orrin Devinsky, Anup D. Patel, Elizabeth A. Thiele et al. · Neurology · 2018 · 451 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

Robert H. Dworkin, Dennis C. Turk, Sarah Peirce‐Sandner et al. · Pain · 2012 · 290 citations

Nursing, Pharmacology, Pharmacotherapy +16

Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders

Eric Hollander, Katherine Tracy, Alan C. Swann et al. · Neuropsychopharmacology · 2003 · 281 citations · Full text

Medicine, Pharmacology, Psychiatry +14

A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis

Frederick G. Freitag, S. D. Collins, H. A. Carlson et al. · Neurology · 2002 · 272 citations

Pharmacy, Pharmacology, Pharmacotherapy +15